1. The entry in the Union list of authorised novel foods as provided for in Article 8 of Regulation (EU) 2015/2283 referring to the substance taxifolin-rich extract shall be amended as specified in the Annex to this Regulation.
2. The entry in the Union list referred to in paragraph 1 shall include the conditions of use and labelling requirements laid down in the Annex to this Regulation.
The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEXSupplementary provisions
ANNEX
The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows:
(1)
The entry for ‘Taxifolin-rich extract’ in Table 1 (Authorised novel foods) is replaced by the following:
Authorised novel food
Conditions under which the novel food may be used
Additional specific labelling requirements
Other requirements
‘ Taxifolin-rich extract
Specified food category
Maximum levels
The designation of the novel food on the labelling of the foodstuffs containing it shall be “taxifolin-rich extract”’
Yogurt plain/Yogurt with fruits (*)
0,020 g/kg
Kephir (*)
0,008 g/kg
Buttermilk (*)
0,005 g/kg
Milk powder (*)
0,052 g/kg
Cream (*)
0,070 g/kg
Sour cream (*)
0,050 g/kg
Cheese (*)
0,090 g/kg
Butter (*)
0,164 g/kg
Chocolate confectionery
0,070 g/kg
Non-alcoholic beverages
0,020 g/l
Food supplements as defined in Directive 2002/46/EC intended for the general population, excluding infants, young children, children and adolescents younger than 14 years
100 mg/day
(*)
When used in milk products Taxifolin-rich extract may not replace in whole or in part, any milk constituent
(2)
The entry for ‘Definition’ for ‘Taxifolin-rich extract’ in in Table 2 (Specifications) is replaced by the following:
Authorised Novel Food
Specification
‘ Taxifolin-rich extract
Definition:
Chemical name: [(2R,3R)-2-(3,4 dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one, also called (+) trans (2R,3R)- dihydroquercetin] and with no more than 2 % of the cis-form’